Page 30 - Glucose Monitoring Devices

References 25

˚
[50] Hansen M, Pedersen-Bjergaard U, Heller S, Wallace T, Rasmussen A, Jørgensen H,
et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Dia-
betes Research and Clinical Practice 2009;85:183e8. https://doi.org/10.1016/
j.diabres.2009.04.022.
[51] Schu ¨tt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, et al. Is the frequency of
self-monitoring of blood glucose related to long-term metabolic control? Multicenter
analysis including 24 500 patients from 191 centers in Germany and Austria. Experi-
mental and Clinical Endocrinology and Diabetes 2006;114:384e8. https://doi.org/
10.1055/s-2006-924152.
[52] Miller K, Beck R, Bergenstal R, Goland R, Haller M, McGill J, et al. Evidence of a
strong association between frequency of self-monitoring of blood glucose and hemo-
globin A1c levels in T1D Exchange clinic registry participants. Diabetes Care 2013;
36:2009e14. https://doi.org/10.2337/dc12-1770.
[53] Simmons J, Chen V, Miller K, McGill J, Bergenstal R, Goland R, et al. Differences in
the management of type 1 diabetes among adults under excellent control compared
with those under poor control in the T1D Exchange clinic registry. Diabetes Care
2013;36:3573e7. https://doi.org/10.2337/dc12-2643.
[54] Levine B, Anderson B, Butler D, Antisdel J, Brackett J, Laffel L. Predictors of glyce-
mic control and short-term adverse outcomes in youth with type 1 diabetes. The Jour-
nal of Pediatrics 2001;139:197e203. https://doi.org/10.1067/mpd.2001.116283.
[55] Moreland E, Tovar A, Zuehlke J, Butler D, Milaszewski K, Laffel L. The impact of
physiological, therapeutic and psychosocial variables on glycemic control in youth
with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism
2004;17. https://doi.org/10.1515/jpem.2004.17.11.1533.
[56] Haller M, Stalvey M, Silverstein J. Predictors of control of diabetes: monitoring may
be the key. The Journal of Pediatrics 2004;144:660e1. https://doi.org/10.1016/
j.jpeds.2003.12.042.
[57] Redondo M, Connor C, Ruedy K, Beck R, Kollman C, Wood J, et al. Pediatric diabetes
consortium type 1 diabetes new onset (NeOn) study: factors associated with HbA1c
levels one year after diagnosis. Pediatric Diabetes 2013;15:294e302. https://doi.org/
10.1111/pedi.12061.
[58] Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. Frequency of
SMBG correlates with HbA1c and acute complications in children and adolescents
with type 1 diabetes. Pediatric Diabetes 2011;12:11e7. https://doi.org/10.1111/
j.1399-5448.2010.00650.x.
[59] Bohn B, Karges B, Vogel C, Otto K, Marg W, Hofer S, et al. 20 Years of pediatric
benchmarking in Germany and Austria: age-dependent analysis of longitudinal
follow-up in 63,967 children and adolescents with type 1 diabetes. PLoS One 2016;
11:e0160971. https://doi.org/10.1371/journal.pone.0160971.
[60] Intensive blood-glucose control with sulphonylureas or insulin compared with conven-
tional treatment and risk of complications in patients with type 2 diabetes (UKPDS
33). The Lancet 1998;352:837e53. https://doi.org/10.1016/s0140-6736(98)07019-6.
[61] Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive in-
sulin therapy prevents the progression of diabetic microvascular complications in Jap-
anese patients with non-insulin-dependent diabetes mellitus: a randomized prospective
6-year study. Diabetes Research and Clinical Practice 1995;28:103e17. https://
doi.org/10.1016/0168-8227(95)01064-k.